Synonyms: hMN-14-SN-38 | hMN-14-SN-38 ADC | IMMU 130 | IMMU-130
Compound class:
Antibody
Comment: Labetuzumab govitecan (research code IMMU-130) is an antibody-drug conjugate (ADC) in which the anti-CEACAM5 antibody labetuzumab, is covalently bound to SN-38, the active metabolite of the topoisomerase inhibitor irinotecan (as exemplified in patents [2] and [1]).
|
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
10096 | labetuzumab govitecan |
Synonyms |
hMN-14-SN-38 | hMN-14-SN-38 ADC | IMMU 130 | IMMU-130 |
Database Links | |
GtoPdb PubChem SID | 249565932 |
Search PubMed clinical trials | labetuzumab govitecan |
Search PubMed titles | labetuzumab govitecan |
Search PubMed titles/abstracts | labetuzumab govitecan |